June 14th, 2018
•Here, we present a protocol to genetically modify primary or expanded human natural killer (NK) cells using Cas9 Ribonucleoproteins (Cas9/RNPs). By using this protocol, we generated human NK cells deficient for transforming growth factor–b receptor 2 (TGFBR2) and hypoxanthine phosphoribosyltransferase 1 (HPRT1).
Tags
Vídeos Relacionados
Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells
Generation of Organotypic Raft Cultures from Primary Human Keratinocytes
Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells
piggyBac Transposon System Modification of Primary Human T Cells
Generation of Human Alloantigen-specific T Cells from Peripheral Blood
Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
Generation of Human Monocyte-derived Dendritic Cells from Whole Blood
Dextran Enhances the Lentiviral Transduction Efficiency of Murine and Human Primary NK Cells
Small RNA Transfection in Primary Human Th17 Cells by Next Generation Electroporation
A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados